Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by Nohandledzepon Jan 28, 2014 5:52pm
207 Views
Post# 22144557

RE:Don't worry.It will be back trading over .50..

RE:Don't worry.It will be back trading over .50..Anytime your stock loses 33% on its highest volume day in nearly a decade, following positive news, some clarification is owed to shareholders... Absolutely and unequivocally!


Unless of course you have a US analyst report that calls for $5, $10 and $22 price targets and this analyst has clients who may want in at the bottom.

Take away the unnecessary "but" and change "soon" to within 2-3 weeks and you have the identical scenario that the Wedbush folks were anticipating and hoping for.

Now, if you wanted to add uncertainty and concern where it isn't warranted, simply make the release as sparse and benign as possible and leave in those two inconsequential words and let your traders sell it into oblivion.
Bullboard Posts